Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for Urticaria Remission after Omalizumab Discontinuation
NCT02742805Phase 4Withdrawn
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of vitamin d in chronic idiopathic urticaria (CIU). Planned start Feb 2016; status: withdrawn.
02
Drugs
vitamin d
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT02742805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742805.